ISTA PHARMACEUTICALS INC Capital Expenditures
ISTA PHARMACEUTICALS INC reported Capital Expenditures of $496.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $496.00K, a 50.30% increase year-over-year.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2011-12-31 was $346.00K, a 82.56% decline year-over-year.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2011-09-30 was $623.00K, a 30.47% decline year-over-year.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for the quarter ending 2011-06-30 was $611.00K.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2011 was $1.91M, a 44.48% decline from fiscal 2010.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2010 was $3.44M, a 161.20% increase from fiscal 2009.
- ISTA PHARMACEUTICALS INC payments to acquire property, plant, and equipment for fiscal 2009 was $1.32M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2012-03-31 | $496.00K 10-Q · filed 2012-05-04 | $842.00K derived: sum of 2 quarters · filed 2012-05-04 | $1.47M derived: sum of 3 quarters · filed 2012-05-04 | $2.08M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $969.00K derived: sum of 2 quarters · filed 2012-02-27 | $1.58M derived: sum of 3 quarters · filed 2012-02-27 | $1.91M 10-K · filed 2012-02-27 |
| 2011-09-30 | $623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.23M derived: sum of 2 quarters · filed 2011-11-07 | $1.56M 10-Q · filed 2011-11-07 | $3.55M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $611.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $941.00K 10-Q · filed 2011-08-01 | $2.92M derived: sum of 3 quarters · filed 2012-05-04 | $3.82M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | $330.00K 10-Q · filed 2012-05-04 | $2.31M derived: sum of 2 quarters · filed 2012-05-04 | $3.21M derived: sum of 3 quarters · filed 2012-05-04 | |
| 2010-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.88M derived: sum of 2 quarters · filed 2012-02-27 | $3.44M 10-K · filed 2012-02-27 | |
| 2010-09-30 | $896.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.46M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $560.00K 10-Q · filed 2011-08-01 | |||
| 2009-12-31 | $1.32M 10-K · filed 2012-02-27 |